Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Alpha Dart Therapy Shows Complete Tumor Clearance in Five Brain Cancer Patients

Alpha Tau Medical Ltd. (NASDAQ:DRTS) on Sunday reported positive interim results from its U.S. REGAIN trial evaluating Alpha DaRT therapy in patients with recurrent glioblastoma. The data capture patient outcomes through November 11, 2026. Strong Tumor Response Rates Clinicians have treated eight patients in the trial so far, and six have reached MRI response assessment. Under RANO criteria, all…

Alpha Dart Therapy Shows Complete Tumor Clearance in Five Brain Cancer Patients

Alpha Tau Medical Ltd. (NASDAQ:DRTS) revealed promising interim results from its U.S. REGAIN trial assessing Alpha DaRT therapy for recurrent glioblastoma in patients. The study, which observed six MRI response assessments, found that all six evaluable patients achieved an objective response according to RANO criteria. An impressive 83.3% of patients, or five individuals, exhibited a complete response with no measurable tumor remaining at the treatment site.

One patient experienced a partial response with a 58% reduction in tumor size. Notably, three patients who had previously shown stable disease following the May 2026 update now display confirmed complete responses after one patient converted from stable disease upon further follow-up. As of November 11, 2026, all eight patients treated remained alive, with a median follow-up of 6.9 months among the six assessed patients.

No unanticipated serious adverse events were observed, and all patients recovered from side effects without lasting symptoms. While no definitive recurrence was detected within the treated zone, four out of six patients displayed asymptomatic necrosis or suspected necrosis near the treated site. Ongoing follow-up and imaging will help determine whether these findings indicate necrosis or tumor progression.

Written by urgent.news from Benzinga's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at benzinga.com →

More in Health & Medicine

More from Monday 16 November →